aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Fuse Biotherapeutics, founded with a mission to revolutionize cancer treatment, focuses on developing innovative immune-modulating therapeutics. The company aims to harness the power of the immune system to create transformative therapies for cancer patients. By leveraging cutting-edge biotechnology, Fuse Biotherapeutics is dedicated to providing novel solutions that improve patient outcomes and address unmet medical needs in oncology.
Notable figures associated with Fuse Biotherapeutics include leading experts in biotechnology and oncology, though specific names are not publicly disclosed. The company has garnered attention for its pioneering approach and potential impact on cancer treatment. While still in its early stages, Fuse Biotherapeutics has made significant strides in research and development, positioning itself as a promising player in the biotech industry.
Operating Status
Active
Ownership Type(s)
Venture Capital, Equity
Main Product(s)
Therapeutics
Technology
Biotech
Tags
Healthtech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Fuse Biotherapeutics founded?
Fuse Biotherapeutics was founded in 2021.
Where is Fuse Biotherapeutics’s headquarters located?
Fuse Biotherapeutics’s headquarters is located in Los Angeles, CA, US.
When was Fuse Biotherapeutics’s last funding round?
Fuse Biotherapeutics’s most recent funding round was for $9.5M (USD) in November 2021.
How many employees does Fuse Biotherapeutics have?
Fuse Biotherapeutics has 5 employees as of Feb 5, 2024.
How much has Fuse Biotherapeutics raised to-date?
As of July 05, 2023, Fuse Biotherapeutics has raised a total of $9.5M (USD) since Nov 15, 2021.
Add Comparison
Total Raised to Date
$9.5M
USD
Last Update Nov 15, 2021
Last Deal Details
$9.5M
USD
Nov 15, 2021
Seed
Total Employees Over Time
5
As of Feb 2024
Fuse Biotherapeutics Address
Los Angeles,
California
90071
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts